UNH vs CVS
UnitedHealth Group Incorporated vs CVS Health Corp. · Updated Nov 9, 2026
UNH — 14 winsCVS — 9 wins
Price Performance
UNH +22.57%CVS +8.14%
Performance
| UNH | CVS | |
|---|---|---|
| 1 Month | +6.10% | -4.68% |
| 3 Months | -3.71% | -12.52% |
| 6 Months | +3.58% | -7.57% |
| YTD | +19.23% | +5.46% |
| 1 Year | +18.97% | +6.55% |
| 3 Year | -21.95% | +12.18% |
| 5 Year | +21.24% | +15.11% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | +17.2% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
| CVS | +4.6% | +79.5% | -44.5% | -15.0% | -10.5% | +48.1% | -7.9% | +13.3% | -10.9% | -9.8% | -18.2% | +2.8% |
Valuation
| UNH | CVS | |
|---|---|---|
| P/E Ratio | 29.72 | 36.87 |
| Forward P/E | 9.99 | 10.28 |
| PEG Ratio | 2.08 | 0.44 |
| P/S Ratio | 0.81 | 0.29 |
| P/B Ratio | 3.49 | 1.51 |
| EV/EBITDA | 14.37 | 8.67 |
Financials
| UNH | CVS | |
|---|---|---|
| EPS (TTM) | $13.24 | $2.27 |
| Gross Margin | +22.74% | +15.56% |
| Operating Margin | +8.05% | +4.66% |
| Net Margin | +5.62% | +2.93% |
| ROE | +11.59% | +3.79% |
| ROA | +3.85% | +1.16% |
| Debt/Equity | 0.75 | 1.01 |
Growth
| UNH | CVS | |
|---|---|---|
| Revenue Growth YoY | +1.96% | +6.17% |
| Revenue Growth QoQ | -1.32% | -4.98% |
| EPS Growth YoY | +0.73% | +63.12% |
| EPS Growth QoQ | +62627.30% | 0.00% |
Technical
| UNH | CVS | |
|---|---|---|
| RSI (14) | 47.35 | 40.74 |
| % From 20-Day SMA | -2.78% | -6.94% |
| % From 50-Day SMA | +0.75% | -7.40% |
| % From 200-Day SMA | +7.95% | -5.85% |
| % From 52-Week High | -14.74% | -24.38% |
| % From 52-Week Low | +53.76% | +20.41% |
Analyst Ratings
UNH
Buy(39 analysts)
Strong SellHoldStrong Buy
Price Target
$478.68
+21.62% upside
CVS
Buy(25 analysts)
Strong SellHoldStrong Buy
Price Target
$109.89
+31.30% upside
Overview
| UNH | CVS | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $363.02B | $116.91B |
| Shares Outstanding | 897.6M | 1.28B |
| Avg Volume (10D) | 5.23M | 13.01M |
| Dividend Yield | 2.24% | 2.91% |
Frequently Asked Questions
Is UNH or CVS a better buy right now?
Based on 23 comparable metrics, UNH leads in 14 categories while CVS leads in 9. UNH has a consensus analyst rating with 39 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, UNH or CVS?
Over the past year, UNH returned +18.97% compared to CVS's +6.55%. In the short term (1 month), UNH returned +6.10% vs CVS's -4.68%.
Is UNH or CVS more expensive?
UNH trades at a P/E of 29.72 compared to CVS's 36.87. On a price-to-sales basis, UNH trades at 0.81x vs CVS's 0.29x. Forward P/E: UNH at 9.99 vs CVS at 10.28.
Which stock has higher growth, UNH or CVS?
UNH's revenue grew +1.96% year-over-year compared to CVS's +6.17%. EPS growth: UNH at +0.73% vs CVS at +63.12%.
Do UNH and CVS pay dividends?
UNH pays a dividend with a yield of 2.24%. CVS pays a dividend with a yield of 2.91%.
Which stock do analysts prefer, UNH or CVS?
UNH has 39 analysts with a target price of $478.68 (+21.62% upside). CVS has 25 analysts with a target of $109.89 (+31.30% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.